Comprehensive multi-omics analysis reveals the prognostic and immune regulatory characteristics of the PTPN family in osteosarcoma
PLOS One · 2025
DOI: 10.1371/journal.pone.0326872 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Changhai Long und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Guangdong Medical University Affiliated Second Hospital, Zhanjiang, Guangdong, China. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms, Protein Tyrosine Phosphatases, Non-Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhanjiang Science and Technology Bureau, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Medical Research Foundation.
Abstract (Originalsprache)
Osteosarcoma is a highly aggressive bone tumor that primarily affects adolescents and young adults, posing significant challenges in therapeutic efficacy, prognostic assessment, and treatment strategies. This study investigates the oncogenic and immune regulatory roles of the PTPN family in osteosarcoma using a comprehensive multi-omics approach. We utilized transcriptomic data, single-cell RNA sequencing (scRNA-seq), and clinical information obtained from publicly available databases. Dimensionality reduction and clustering techniques were employed to subclassify immune cells and analyze the tumor microenvironment characteristics. We identified prognostic genes associated with the PTPN family and stratified osteosarcoma cases into distinct molecular subtypes using consensus clustering. A random forest model revealed that the PTPN family has a significant impact on prognosis and modulates key oncogenic pathways. Furthermore, we analyzed the role of the PTPN family in regulating immune cells and selected PTPN23 for experimental validation. This research not only enhances prognostic assessments in osteosarcoma but also establishes a foundation for personalized therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Guangdong Medical University Affiliated Second Hospital, Zhanjiang, Guangdong, China.
- Department of Pharmacy, Guangdong Medical University Affiliated Second Hospital, Zhanjiang, Guangdong, China.
- Department of Joint Surgery II, Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming, Guangdong, China.
ORCID-Profile: Sijing Liu
Förderung
- Zhanjiang Science and Technology Bureau
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Guangdong Medical Research Foundation
Zitieren
APA
Long, C., Ma, B., Zhong, X., Zou, M., Li, K., & Liu, S. (2025). Comprehensive multi-omics analysis reveals the prognostic and immune regulatory characteristics of the PTPN family in osteosarcoma. PLOS One. https://doi.org/10.1371/journal.pone.0326872
Vancouver
Long C, Ma B, Zhong X, Zou M, Li K, Liu S. Comprehensive multi-omics analysis reveals the prognostic and immune regulatory characteristics of the PTPN family in osteosarcoma. PLOS One. 2025. doi:10.1371/journal.pone.0326872
BibTeX
@article{Long2025,
author = {Long, Changhai and Ma, Biao and Zhong, Xingshun and Zou, Mingzhi and Li, Kai and Liu, Sijing},
title = {Comprehensive multi-omics analysis reveals the prognostic and immune regulatory characteristics of the PTPN family in osteosarcoma},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0326872}
}
EUVIMED